Need for evidence-based approach to benzodiazepine dependence in opioid agonist treatment.  Chalabianloo F, Askjer JF, Blomkvist AW, Dale KS, Sundal C, Rønning BH, Butt WSJ, Zavenova S, Ørmen AG, Andersen CD, Johansson KA, Fadnes LT, Mordal J…

Use of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case series.  Wong A, Nolan S, Bach P, Janssen RM, De Wolfe…

Association between benzodiazepines and dementia: A case-control study from Canadian health surveys and medico-administrative databases.  Legrand D, Roberge P, Vanasse A, Carrier N, Bocti C.  J Neurol Sci. 2025 Dec 15;479:123746. doi: 10…

Benzodiazepine Use Among Patients Receiving Methadone Maintenance Treatment: A Descriptive Study.  Liu Y, Hong Q, Shen W, Li L, Li Z, Zhou W, Xie X.  Drug Des Devel Ther. 2026 Feb 24;20:579917. doi: 10.2147/DDDT.S579917. PMID: 41769266;…

Benzodiazepine Dependence: Clinical and Molecular Aspects, Preventive Strategies and Therapeutic Approaches.  Navarrete F, Marín-Mayor M, Martínez-Hostyn L, Rubio G, Manzanares J.  Int J Mol Sci. 2026 Jan 31;27(3):1430. doi: 10.3390/ijms…

UK: Zusätzliche Warnhinweise für Benzodiazepine, Gabapentin, Pregabalin und Z-Drugs Die britische Arzneimittelbehörde MHRA verstärkt Warnungen vor Sucht, Abhängigkeit, Entzugssyndrom und Toleranzentwicklung in Fachinformationen und Packungsbeilagen…